Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-23-000015

Business Development Director sold 11,707 shares at $1.40 ($16,390)

From the SEC's structured data for this filing

Trades in this filing

Christianson Mark · Business Development Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-21 Sale : show line 1 in the form −9,907 $1.40 $13,870 340,687 D
2023-12-22 Sale : show line 2 in the form −1,800 $1.40 $2,520 338,887 D
Open-market sales · 11,707 sh · avg $1.40 · $16,390
Loading xslF345X05/primary_doc.xml…